ARCHIVES

Survey Finds 70 Percent of Oncologists Prescribe Avastin Off-Label For Ovarian Cancer

This article is from The Cancer Letter archive.

Vol. 36 No. 8 | August 30, 2013

Download PDF Visit The Full Archive

Related Articles

In Brief: Jennifer Pietenpol Named to IOM Cancer Policy Board

July 18, 2014

Satraplatin Improved PFS In Refractory Prostate Cancer

July 25, 2003

Sister Study To Examine Risk Factors For Breast Cancer In 50,000 Women

October 29, 2004

House Appropriations by Institute

July 8, 1994

Analysis Reveals Patient Subset With Lower PFS in Phase III Trial

December 30, 2011

Amgen’s Aranesp Sales Dropped By Half, Continue To Fall.

November 14, 2008